GlassScriptPhysician profile
Avinash Inabathula
NPI 1497249049
$24,118.26
in general payments reported to CMS, 2019-2025
9 companies · $4,471 in 2025
The $4,471 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.14 · 2021: $4,405 · 2022: $2,090 · 2023: $5,991 · 2024: $7,081 · 2025: $4,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,798 · Food and Beverage: $4,559 · Education: $2,686 · Grant: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,798.35 |
| Food and Beverage | $4,558.59 |
| Education | $2,686.19 |
| Grant | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,912.63 | 2023-2024 | Microraptor, Real Intelligence, Fast-Fix |
| Zimmer Biomet Holdings, INC. | $4,412.35 | 2021-2025 | Persona, Avenir, Rosa |
| Stryker Corporation | $4,205.12 | 2021-2025 | Mako, Insignia, N/A |
| Wardlow Enterprises | $3,600.00 | 2021-2022 | |
| Encore Medical, LP | $1,626.49 | 2024-2025 | Djo Surgical |
| Medical Device Business Services, INC. | $1,351.82 | 2021-2024 | Velys |
| Depuy Synthes Sales INC. | $856.40 | 2019-2023 | Velys |
| Next Science LLC | $91.00 | 2023-2024 | Xperience, Blastx, Surgx |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Inabathula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.